Paco Eduardo Bravo

From Wikitia
Jump to navigation Jump to search
Paco Eduardo Bravo
Born
Cali, Colombia
Alma materUniversidad del Valle
Known forMolecular imaging in cardiovascular diseases
Scientific career
FieldsNuclear Medicine, Cardiology, Cardiovascular Imaging
InstitutionsHospital of the University of Pennsylvania
WebsiteFaculty page

Paco Eduardo Bravo is a Colombian physician specialized in nuclear medicine and cardiology. He is an Assistant Professor of Radiology at the Hospital of the University of Pennsylvania and serves as its Director of Nuclear Cardiology. His research focuses on molecular imaging techniques for the diagnosis and monitoring of cardiovascular diseases.

Education

Bravo earned his medical degree from the University of Valle of Colombia in 2002.[1] He completed a residency in internal medicine at the University of Alabama at Birmingham and a residency in nuclear medicine at Johns Hopkins Hospital.[2] He later completed fellowships in cardiology at Brigham and Women's Hospital and the University of Washington Medical Center.[2]

Professional career

Bravo has held several academic and clinical positions at the University of Pennsylvania including Assistant Professor of Radiology, Director of Nuclear Cardiology, Co-director of the Cardiovascular Phenotyping Unit at the Center for Human Phenomic Science (CHPS), Vice Chair of the Radiation Safety Research Oversight Committee,[1] and Chair of the Nuclear Cardiology Governance Committee at Penn Medicine.[1]

Bravo is certified by the American Board of Internal Medicine and by the American Board of Nuclear Medicine.[2] He is a member of the American College of Cardiology.[3]

Scientific production and research areas

Bravo's research focuses on molecular imaging and tissue characterization in cardiovascular diseases. He has authored over 170 peer-reviewed articles and book chapters. As of June 2025, Bravo's h-index was 42 according to Google Scholar.[4]

Myocardial inflammation and cardiac sarcoidosis

Bravo has studied the use of fluorodeoxyglucose positron emission tomography (¹⁸F-FDG PET) to evaluate myocardial inflammation, particularly in patients with cardiac sarcoidosis.[5] His work includes dietary preparation protocols such as ketogenic diets,[6] and the use of SGLT2 inhibitors to suppress physiological myocardial glucose uptake.[7]

Infiltrative diseases

Bravo has contributed to the diagnosis of cardiac amyloidosis using 99mTc-PYP SPECT/CT imaging,[8] and to the development of artificial intelligence tools for automated detection.[9] He has also studied early detection of cardiac allograft vasculopathy via PET/CT myocardial flow quantification.[10]

Cardiovascular infections and implanted devices

Bravo participated in international consensus statements on the use of PET/CT and SPECT/CT (with radiolabeled leukocytes) to evaluate cardiovascular infections, including infective endocarditis and device-related complications.[11]

Imaging innovations and machine learning

His research includes deep learning methods for automatic myocardial segmentation in cardiac imaging studies.[12] He has also studied advanced MRI and PET tracers to assess oxidative stress and subclinical inflammation.[13]

Lectures and conference presentations

Bravo has participated as a lecturer and invited speaker in multiple international scientific meetings related to nuclear cardiology and cardiovascular imaging.

  • 2025 – Society for Cardiovascular Magnetic Resonance (SCMR) Annual Conference[14]
  • 2024 – American Society of Nuclear Cardiology (ASNC) Scientific Session and Exhibition[15]
  • 2020 – North American Society for Cardiovascular Imaging (NASCI) Annual Meeting[16]

Professional recognition and contributions

  • Editorial author in *JACC: Cardiovascular Imaging* (2024)[17]
  • Faculty, ASNC Virtual Elective[18]
  • Panelist, ASNC Future Leaders Program (2025)[19]
  • Member, ASNC Guidelines & Scientific Statements Committee[20]

Awards and honors

  • 2019 – Blavatnik Family Fellowship, University of Pennsylvania[21]

References

  1. ↑ 1.0 1.1 1.2 "Paco E. Bravo | Faculty | About Us | Perelman School of Medicine | Perelman School of Medicine at the University of Pennsylvania". www.med.upenn.edu. Retrieved 2025-06-05.
  2. ↑ 2.0 2.1 2.2 "Paco E Bravo, MD | Tower Health". towerhealth.org. Retrieved 2025-06-05.
  3. ↑ https://www.acc.org/membership/person?id=15c41c48-1f04-41a3-a526-40d467bb292c
  4. ↑ "Bravo, Paco E." scholar.google.com. Retrieved 2025-06-05.
  5. ↑ Bourque, Jamieson M.; Birgersdotter-Green, Ulrika; Bravo, Paco E.; Budde, Ricardo P. J.; Chen, Wengen; Chu, Vivian H.; Dilsizian, Vasken; Erba, Paola Anna; Gallegos Kattan, Cesia; Habib, Gilbert; Hyafil, Fabien; Khor, Yiu Ming; Manlucu, Jaimie; Mason, Pamela Kay; Miller, Edward J. (June 2024). "18F-FDG PET/CT and Radiolabeled Leukocyte SPECT/CT Imaging for the Evaluation of Cardiovascular Infection in the Multimodality Context: ASNC Imaging Indications (ASNC I2) Series Expert Consensus Recommendations From ASNC, AATS, ACC, AHA, ASE, EANM, HRS, IDSA, SCCT, SNMMI, and STS". JACC. Cardiovascular Imaging. 17 (6): 669–701. doi:10.1016/j.jcmg.2024.01.004. ISSN 1876-7591.
  6. ↑ Bourque, Jamieson M.; Birgersdotter-Green, Ulrika; Bravo, Paco E.; Budde, Ricardo P. J.; Chen, Wengen; Chu, Vivian H.; Dilsizian, Vasken; Erba, Paola Anna; Gallegos Kattan, Cesia; Habib, Gilbert; Hyafil, Fabien; Khor, Yiu Ming; Manlucu, Jaimie; Mason, Pamela Kay; Miller, Edward J. (May 2024). "18F-FDG PET/CT and radiolabeled leukocyte SPECT/CT imaging for the evaluation of cardiovascular infection in the multimodality context: ASNC Imaging Indications (ASNC I2) Series Expert Consensus Recommendations from ASNC, AATS, ACC, AHA, ASE, EANM, HRS, IDSA, SCCT, SNMMI, and STS". Heart Rhythm. 21 (5): e1–e29. doi:10.1016/j.hrthm.2024.01.043. ISSN 1556-3871.
  7. ↑ Bourque, Jamieson M.; Birgersdotter-Green, Ulrika; Bravo, Paco E.; Budde, Ricardo P. J.; Chen, Wengen; Chu, Vivian H.; Dilsizian, Vasken; Erba, Paola Anna; Gallegos Kattan, Cesia; Habib, Gilbert; Hyafil, Fabien; Khor, Yiu Ming; Manlucu, Jaimie; Mason, Pamela Kay; Miller, Edward J. (April 2024). "18F-FDG PET/CT and radiolabeled leukocyte SPECT/CT imaging for the evaluation of cardiovascular infection in the multimodality context: ASNC Imaging Indications (ASNC I2) Series Expert Consensus Recommendations from ASNC, AATS, ACC, AHA, ASE, EANM, HRS, IDSA, SCCT, SNMMI, and STS". Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology. 34: 101786. doi:10.1016/j.nuclcard.2023.101786. ISSN 1532-6551.
  8. ↑ Bravo, Paco E. (June 2024). "Early Evaluation of Cardiac Allograft Vasculopathy With Myocardial Blood Flow PET/CT: How Early Is Too Early?". JACC. Cardiovascular Imaging. 17 (6): 656–658. doi:10.1016/j.jcmg.2024.04.002. ISSN 1876-7591.
  9. ↑ Selvaraj, Senthil; Bravo, Paco E. (August 2024). "How to prepare a patient for 18F-fluorodeoxyglucose positron emission tomography imaging to assess myocardial inflammation". Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology. 38 101888. doi:10.1016/j.nuclcard.2024.101888. ISSN 1532-6551.
  10. ↑ Bourque, Jamieson M.; Birgersdotter-Green, Ulrika; Bravo, Paco E.; Budde, Ricardo P. J.; Chen, Wengen; Chu, Vivian H.; Dilsizian, Vasken; Erba, Paola Anna; Gallegos Kattan, Cesia; Habib, Gilbert; Hyafil, Fabien; Khor, Yiu Ming; Manlucu, Jaimie; Mason, Pamela Kay; Miller, Edward J. (2024-03-11). "18F-FDG PET/CT and radiolabeled leukocyte SPECT/CT imaging for the evaluation of cardiovascular infection in the multimodality context: ASNC Imaging Indications (ASNC I2) Series Expert Consensus Recommendations from ASNC, AATS, ACC, AHA, ASE, EANM, HRS, IDSA, SCCT, SNMMI, and STS". Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America ciae046. doi:10.1093/cid/ciae046. ISSN 1537-6591.
  11. ↑ Bourque, Jamieson M.; Birgersdotter-Green, Ulrika; Bravo, Paco E.; Budde, Ricardo P. J.; Chen, Wengen; Chu, Vivian H.; Dilsizian, Vasken; Erba, Paola Anna; Gallegos Kattan, Cesia; Habib, Gilbert; Hyafil, Fabien; Khor, Yiu Ming; Manlucu, Jaimie; Mason, Pamela Kay; Miller, Edward J. (2024-03-11). "18F-FDG PET/CT and radiolabeled leukocyte SPECT/CT imaging for the evaluation of cardiovascular infection in the multimodality context: ASNC Imaging Indications (ASNC I2) Series Expert Consensus Recommendations from ASNC, AATS, ACC, AHA, ASE, EANM, HRS, IDSA, SCCT, SNMMI, and STS". Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America ciae046. doi:10.1093/cid/ciae046. ISSN 1537-6591.
  12. ↑ Selvaraj, Senthil; Bravo, Paco E. (August 2024). "How to prepare a patient for 18F-fluorodeoxyglucose positron emission tomography imaging to assess myocardial inflammation". Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology. 38 101888. doi:10.1016/j.nuclcard.2024.101888. ISSN 1532-6551.
  13. ↑ Vidula, Mahesh K.; Selvaraj, Senthil; Rojulpote, Chaitanya; Bhattaru, Abhijit; Kc, Wumesh; Hansbury, Mary; Schubert, Erin; Clancy, Caitlin B.; Rossman, Milton; Goldberg, Lee R.; Farwell, Michael; Pryma, Daniel; Bravo, Paco E. (August 2024). "Relationship of Ketosis With Myocardial Glucose Uptake Among Patients Undergoing FDG PET/CT for Evaluation of Cardiac Sarcoidosis". Circulation. Cardiovascular Imaging. 17 (8): e016774. doi:10.1161/CIRCIMAGING.124.016774. ISSN 1942-0080.
  14. ↑ "Browse by Speaker".
  15. ↑ "ASNC2024 Scientific Session and Exhibition Meeting OnDemand". education.asnc.org. Retrieved 2025-06-05.
  16. ↑ https://www.nasci.org/wp-content/uploads/2020/08/NASCI-2020-Brochure_Virtual-Meeting_proof12.pdf
  17. ↑ Bravo, Paco E. (June 2024). "Early Evaluation of Cardiac Allograft Vasculopathy With Myocardial Blood Flow PET/CT: How Early Is Too Early?". JACC. Cardiovascular Imaging. 17 (6): 656–658. doi:10.1016/j.jcmg.2024.04.002. ISSN 1876-7591.
  18. ↑ "ASNC Nuclear Cardiology Virtual Elective – ASNC". asnc.org. Retrieved 2025-06-05.
  19. ↑ "Future Leaders: The Next Generation of Nuclear Cardiology". asnc.org. Retrieved 2025-06-05.
  20. ↑ "Committees - ASNC". asnc.org. Retrieved 2025-06-05.
  21. ↑ "Volume 65 Number 4". almanac.upenn.edu. Retrieved 2025-06-05.

External links

Add External links

This article "Paco Eduardo Bravo" is from Wikipedia. The list of its authors can be seen in its historical. Articles taken from Draft Namespace on Wikipedia could be accessed on Wikipedia's Draft Namespace.

Retrieved from "https://wikitia.com/index.php?title=Paco_Eduardo_Bravo&oldid=221024"